Molecular Mechanism Study of Uterine Sarcoma

Launched by SHIXUAN WANG · May 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying uterine sarcoma, a type of cancer that occurs in the uterus. Researchers want to understand the key factors that contribute to its development and progression using advanced technology that looks at different biological information, known as multi-omics. This study is currently recruiting female participants aged 18 and older who have either newly diagnosed uterine sarcoma or have had a recurrence of the disease.

To be eligible for the trial, participants must not have been diagnosed with any other cancers in the past five years and should not have received pelvic or vaginal radiation therapy. If you join this study, you can expect to undergo various tests that will help researchers learn more about uterine sarcoma. Your contribution could help improve future treatments and understanding of this disease.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18 or older;
• • 2. Newly treated or recurenced uterine sarcoma.
• Exclusion Criteria:
• • 1. Diagnosis of other malignancies within the past 5 years;
• • 2. history of pelvic or vaginal radiation therapy;
• • 3. Known high-grade lesions of the cervix and endometrium.